Morphine Sulfate Injection, Solution
Product Images NDC 0409-1891

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0409-1891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Morphine 01)

FDA Label Image

Logo (Morphine 02)

FDA Label Image

Figure (Morphine 03)

FDA Label Image

Figure (Morphine 04)

FDA Label Image

Figure (Morphine 05)

FDA Label Image

Figure (Morphine 06)

FDA Label Image

Figure (Morphine 07)

FDA Label Image

Figure (Morphine 08)

FDA Label Image

Principal Display Panel (2 mg/mL Cartridge Label)

Principal Display Panel (2 mg/mL Cartridge Label)
This text includes information about a single-dose Carpuject™ sterile cartridge unit with Luer Lock intended for intravenous use only. It provides guidelines such as protecting from light and freezing, and mentions that it is distributed by Hospira, Inc. Additional details like lot number and expiration date are also included.*
FDA Label Image

Principal Display Panel (2 mg/mL Syringe Label)

Principal Display Panel (2 mg/mL Syringe Label)
This text is a description of a single-use pre-filled syringe for intravenous use by Hospira, Inc. The syringe features a Luer Lock and should be protected from light and freezing. The product should be opened by twisting and is for prescription use only. Note the product details including NDC number, volume, and manufacturer information.*
FDA Label Image

Principal Display Panel (2 mg/mL Cartridge Carton)

Principal Display Panel (2 mg/mL Cartridge Carton)
This document appears to be detailing information about a medication product, specifically Morphine Sulfate Injection, USP. It includes details such as the concentration of the solution (2 mg/mL), ingredients present, storage instructions, usage guidelines, and the requirement to use with specific Carpuject Holders. The document emphasizes that the injection is for intravenous use only and provides cautions regarding the appearance of the solution to ensure quality. Additionally, it mentions the need to protect the solution from light and freezing. The text also references the need to check the insert for usual dosage and provides storage temperature guidance.*
FDA Label Image

Principal Display Panel (2 mg/mL Syringe Carton)

Principal Display Panel (2 mg/mL Syringe Carton)
This product is a morphine sulfate injection intended for intravenous use only. Each mL contains 2 mg of morphine sulfate. It is crucial to protect the injection from light and to retain it in the original carton until use. The prefilled syringe is a single-use item with a Luer Lock. The typical storage temperature is between 20 to 25 degrees Celsius to maintain its efficacy. It is also important to follow the instructions provided on the insert for the recommended dosage.*
FDA Label Image

Principal Display Panel (4 mg/mL Cartridge Label)

Principal Display Panel (4 mg/mL Cartridge Label)
Description: This product is a single-dose Carpuject™ Sterile Cartridge Unit with Luer Lock containing Morphine Sulfate Injection USP at a concentration of 4 mg/mL intended for intravenous use only. It is distributed by Hospira, Inc. and should be protected from light and freezing. The product is labeled with an NDC code and lot number for tracking and expiration date for quality assurance.*
FDA Label Image

Principal Display Panel (4 mg/mL Syringe Label)

Principal Display Panel (4 mg/mL Syringe Label)
This text contains information about a single-use prefilled syringe of Morphine Sulfate Injection for intravenous use. The syringe has a Luer Lock mechanism for secure connection. It is important to protect the product from light and freezing. The manufacturer is Hospira, Inc. located in Lake Forest, Illinois, USA.*
FDA Label Image

Principal Display Panel (4 mg/mL Cartridge Carton)

Principal Display Panel (4 mg/mL Cartridge Carton)
This is a description of a Morphine Sulfate Injection, USP product in a Carpuject™ Slim-Pak™ Cartridge format. The injection is for intravenous use only and each mL contains morphine sulfate and other components. The packaging includes specific instructions for usage, storage conditions, and details on precautions such as avoiding use if the color is abnormal or contains a precipitate. The product is to be used with specified Carpuject holders, and the dosage information can be found in the package insert. The manufacturer and distribution information is also provided on the packaging.*
FDA Label Image

Principal Display Panel (4 mg/mL Syringe Carton)

Principal Display Panel (4 mg/mL Syringe Carton)
This text provides information about iSecyrs, a morphine sulfate injection in a prefilled syringe for intravenous use. The syringe is single-use and comes with a Luer Lock, but the needle is not included. It contains 4 mg of morphine sulfate per mL and should be stored at 20 to 25°C, protected from light and freezing. The manufacturer is Hospira, and the product is preservative-free and sterile. Users are advised not to use the injection if its color is darker than pale yellow or if it appears discolored or contains a precipitate. The text also includes the drug's composition and dosage recommendations.*
FDA Label Image

Principal Display Panel (8 mg/mL Cartridge Label)

Principal Display Panel (8 mg/mL Cartridge Label)
This is a description of a single-dose Carpuject™ containing Morphine Sulfate Injection, USP at a concentration of 8 mg/mL for intravenous use only. The product is in a sterile cartridge unit with Luer Lock and should be protected from light and freezing. It is distributed by Hospira, Inc.*
FDA Label Image

Principal Display Panel (8 mg/mL Syringe Label)

Principal Display Panel (8 mg/mL Syringe Label)
This is a single-use prefilled syringe with a twist-to-open mechanism and a Luer Lock tip containing Morphine Sulfate Injection, USP. It is intended for intravenous use only and should be protected from light and freezing. The product is manufactured by Hospira in Lake Forest, IL, USA and is labeled with the NDC code 0403-1892-10.*
FDA Label Image

Principal Display Panel (8 mg/mL Cartridge Carton)

Principal Display Panel (8 mg/mL Cartridge Carton)
The text provides detailed information about a morphine sterile aqueous injection product, including its concentration, components, proper usage, storage conditions, and safety precautions. It specifies that the injection should only be used intravenously, and the importance of checking for color, clarity, and precipitates before use. The product comes in single-dose Carpuject™ cartridges to be used with specific holders and must be protected from freezing and light. Additional instructions on dosage, storage temperature, and compatibility with Carpuject holder are also included.*
FDA Label Image

Principal Display Panel (8 mg/mL Syringe Carton)

FDA Label Image

Principal Display Panel (10 mg/mL Cartridge Label)

FDA Label Image

Principal Display Panel (10 mg/mL Syringe Label)

Principal Display Panel (10 mg/mL Syringe Label)
This product is a 1 mL single-use pre-filled syringe with a Luer Lock for injection use. It contains Morphine Sulfate and should only be used intravenously. It is important to protect it from light and freezing. The manufacturer is Hospira, Inc.*
FDA Label Image

Principal Display Panel (10 mg/mL Cartridge Carton)

Principal Display Panel (10 mg/mL Cartridge Carton)
This document appears to be a description and instructions for the use of Morphine Sulfate Injection, USP. It mentions the concentration of morphine, the recommended use for intravenous administration only, and instructions for storage and handling. The product is presented in a sterile cartridge unit and is intended for single-dose use with a specific holder. Additionally, it highlights the preservative-free nature of the injection and provides details on the components of the solution. Special attention is given to the appearance of the injection before use and recommendations for storage. The text also references a tamper detection package for security purposes. Furthermore, it includes information about the manufacturer, Hospira Inc., based in Lake Forest, USA.*
FDA Label Image

Principal Display Panel (10 mg/mL Syringe Carton)

Principal Display Panel (10 mg/mL Syringe Carton)
This text appears to be a product description for a single-use pre-filled syringe containing Morphine Sulfate for injection use. The syringe comes with a Luer Lock but does not include a needle. The solution in the syringe is preservative-free and sterile, with a concentration of 10 mg/mL. It is intended for intravenous use only and should be protected from light. The syringe should be retained in the carton until the time of use and stored at a temperature between 20 to 25°C. The manufacturer is Hospira Inc. The text also includes information on the contents of the solution, storage instructions, and warnings related to the color and appearance of the injection.*
FDA Label Image

Principal Display Panel (15 mg/mL Syringe Label)

FDA Label Image

Principal Display Panel (15 mg/mL Syringe Label)

Principal Display Panel (15 mg/mL Syringe Label)
This is a single-use, prescription-only syringe with a Luer Lock containing Morphine Sulfate Injection USP solution with a concentration of 5 mg/mL for intravenous use. It is important to protect this product from light and freezing. Manufactured by Hospira, Inc. in Lake Forest, IL. The syringe has a twist-to-open mechanism for easy access.*
FDA Label Image

Principal Display Panel (15 mg/mL Syringe Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.